Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/11/2025

Management of Beta Blockers in Patients with Cardiovascular Disease

Introduction to Beta Blocker Management

  • The American College of Cardiology and the American Heart Association recommend continuing beta blockers in patients undergoing surgery who are receiving beta blockers for treatment of conditions with ACCF/AHA Class I guideline indications (Level of Evidence: C) 1, 2
  • For a patient with cardiovascular disease, age over 65 is itself a risk factor for perioperative cardiovascular complications, and patients with established cardiovascular disease benefit from continued beta blockade through the perioperative period 1

Preoperative Assessment and Management

  • Verify the indication for beta blockers (e.g., hypertension, coronary artery disease, heart failure, arrhythmia) and check vital signs, particularly heart rate (ensure it's not bradycardic, ideally 60-80 bpm) 1
  • Assess for any contraindications to continuing beta blockade (e.g., severe bradycardia, hypotension, high-degree heart block) 1

Perioperative Management

  • Administer the usual dose of beta blockers on the morning of surgery with a small sip of water, and monitor heart rate and blood pressure closely during the perioperative period 1, 2
  • If oral administration is not possible postoperatively, consider IV beta blockers at equivalent dosing until oral intake is resumed 1, 2

Postoperative Management

  • Resume oral beta blockers as soon as the patient can take medications by mouth, continue to monitor for bradycardia, hypotension, or heart block, and ensure beta blockers are included in discharge medications 1
  • Dose titration may be needed: if hemodynamic instability occurs, temporary dose reduction rather than complete discontinuation is preferred 1
  • Monitoring requirements: close monitoring of heart rate and blood pressure is essential, especially in the immediate postoperative period 2

Special Considerations for Heart Failure Patients

  • For patients with heart failure, beta blockers provide mortality benefit and should be continued unless hemodynamically unstable 3
  • The American College of Cardiology recommends holding metoprolol if a patient shows signs of worsening heart failure, including increased dyspnea at rest, new or worsening peripheral edema, increased jugular venous distention, and S3 gallop on examination 4, 5
  • For patients with heart failure, the American College of Cardiology and the American Heart Association recommend resuming metoprolol at a lower dose when heart rate returns to >60 bpm and systolic blood pressure >100 mmHg, and then titrating gradually back to target dose, as beta-blockers reduce mortality in heart failure patients 4, 5

Special Considerations for Patients with Diabetes

  • The American Diabetes Association suggests considering holding beta blockers if a patient has recurrent hypoglycemic episodes without awareness 6

Evidence and Recommendations

  • The evidence strongly supports continuing beta blockers throughout the perioperative period in patients already receiving this medication for cardiovascular indications, as the risks of discontinuation outweigh the potential risks of continuation 1, 2